Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:38:19 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



News for U:APLIF from 2023-05-07 to 2024-05-06 - 16 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-26 19:03U:APLIFNews ReleaseAppili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
2024-04-02 08:30U:APLIFNews ReleaseAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
2024-04-02 07:30U:APLIFNews ReleaseAppili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.
2024-03-12 07:12U:APLIFNews ReleaseResearchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks
2023-12-15 07:27U:APLIFNews ReleaseAppili Therapeutics Announces Issuance of Patent for ATI-1701 Biodefense Vaccine Candidate to Protect Against Tularemia and Provides Update on Bridge Loan
2023-11-13 16:24U:APLIFNews ReleaseAppili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2024
2023-10-25 07:49U:APLIFNews ReleaseAppili Therapeutics ¢ € ™ Biodefense Vaccine Candidate ATI-1701 is Awarded Additional Funding from the U.S. Air Force Academy
2023-09-27 19:21U:APLIFNews ReleaseAppili Therapeutics Announces Results of Annual Meeting of Shareholders and Provides Corporate Update
2023-09-27 07:27U:APLIFNews ReleaseAppili Therapeutics Presents at the 10th International Tularemia Conference
2023-09-25 07:54U:APLIFNews ReleaseAppili Therapeutics Announces U.S. FDA Approval of LIKMEZ ¢ „ ¢ (ATI-1501) Metronidazole Oral Suspension
2023-08-11 16:50U:APLIFNews ReleaseAppili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2024
2023-06-29 07:26U:APLIFNews ReleaseAppili Therapeutics Announces Bridge Loan from Bloom Burton & Co.
2023-06-23 17:07U:APLIFNews ReleaseAppili Therapeutics ¢ € “ Press Release Correction
2023-06-23 07:21U:APLIFNews ReleaseAppili Therapeutics Reports Fiscal Year 2023 Financial and Operational Results
2023-05-24 07:19U:APLIFNews ReleaseAppili Therapeutics Announces Issuance of Patent for ATI-1501 Liquid Oral Reformulation of Metronidazole
2023-05-08 07:38U:APLIFNews ReleaseAppili Therapeutics Secures Contract for ATI-1701 Funding from the U.S. Air Force Academy